REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
MYDIAL IBD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/17/2026
Trademark type
Combined
Nice classes
10
Filing date
09/18/2020
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
SOTLAND, THEODORE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MYDIAL IBD", with the word "MYDIAL" centered above a circle containing the word "IBD", all of the forgoing contained within a larger circle.
Holders and representatives
Holders
IBD ITALIAN BIOMEDICAL DEVICES S.r.l.
Representatives
Paulo A. de Almeida Patel & Almeida, P.C.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Surgical instruments and apparatus; medical apparatus and instruments used in kidneys diseases treatmentdialysis machineshemodialysis machinesdevices for treating impaired renal function and for removal of water and salt from the body; needles for medical purposes; dialyzers; hemodialysis apparatus; nuclear medicine diagnostic imaging apparatus; medical apparatus for monitoring vital signsblood pressureheart raterenal function; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatusmedical device for obtaining body fluid samples; medical diagnostic apparatus for testing used in kidneys diseases treatment; blood testing apparatus; testing apparatus for medical purposes used in kidneys diseases treatment; cannulae; catheters; devices for the preparation of pharmaceutical preparations and blood products for the treatment of kidney diseasesintravenous bags sold empty for intravenous therapy and blood drawing apparatus; nebulizers for medical purposes; medical endoscopes; droppers for administering medicationsold empty; dropper bottles for administering medicationsold empty; intravenous feeding bottles; inhalers for medical purposessold empty; fluid injectors for medical purposes; enema apparatus for medical purposes; implantable drug delivery pumps; X-ray photographs for medical purposes; medical apparatus in the nature of receptacles for applying medicines; surgical robots; infusion sets; syringes for medical purposes; probes for medical purposes; stents; capillary tubes for blood; capillary reagent tubes; receptacles for the collection of liquids for medical usemedical specimen collection devices in the nature of glassslidescupsbags for the collection of bloodurinefecal matter; medical tubing for administering drugs; infusions apparatus for medical purposesinfusion sets and replacement parts thereof; body fluid drainage apparatus for medical purposes and replacement parts thereofused for the treatment of kidney diseases
Publications
History of USPTO decisions and trademark events.
28 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/31/2022
FIMP
FINAL DISPOSITION PROCESSED
01/31/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/17/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/01/2021
PUBO
PUBLISHED FOR OPPOSITION
06/01/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/27/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/27/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/27/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/24/2021
RFNT
REFUSAL PROCESSED BY IB
03/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/20/2021
RFRR
REFUSAL PROCESSED BY MPU
02/19/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2021
CNRT
NON-FINAL ACTION WRITTEN
02/10/2021
DOCK
ASSIGNED TO EXAMINER
02/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/12/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens MYDIAL IBD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.